EFTR
Effector Therapeutics Inc
NASDAQ: EFTR · HEALTHCARE · BIOTECHNOLOGY
$0.00
+0.00% today
Updated 2026-04-30
Market cap
$940.00
P/E ratio
—
P/S ratio
69.65x
EPS (TTM)
$-12.57
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
Effector Therapeutics Inc (EFTR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-25.2%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-800.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2024-03-31 | $-2.16 | $-2.16 | +0.0% | — | — |
| 2023-12-31 | $-1.65 | $-3.42 | -107.3% | $162000.00 | -76.0% |
| 2023-09-30 | $-0.12 | $-0.13 | -8.3% | — | — |
| 2023-06-30 | $-0.20 | $-0.17 | +15.0% | — | — |
| 2023-03-31 | $-0.14 | $-0.24 | -71.4% | — | — |
| 2022-12-31 | $-0.24 | $-0.22 | +8.3% | $675000.00 | -52.8% |
| 2022-09-30 | $-0.21 | $-0.23 | -9.5% | $867000.00 | +103.0% |
| 2022-06-30 | $-0.16 | $-0.17 | -6.3% | $2.01M | +190.6% |
| 2022-03-31 | $-0.24 | $0.07 | +129.2% | — | — |
| 2021-12-31 | $-0.24 | $0.44 | +283.3% | $1.43M | — |
| 2021-09-30 | $-0.20 | $0.42 | +310.0% | $427000.00 | — |
| 2021-06-30 | $-0.29 | $-0.37 | -29.8% | $692000.00 | — |
Frequently asked questions
Has Effector Therapeutics Inc beaten earnings estimates?
Effector Therapeutics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -25.2% over the last 4 quarters.